ITGAL and cancer: Pre-treatment of CD8+ T cells with anti-CD11a antibodies (LFA-1 blockade), reduced CD69 and CD44 expressions on T cells after co-culture experiments (Fig. 3e), indicating that ICAM1 on cancer cells mediates the interaction with T cells by binding to LFA-1.